Scientists' Profiles

Professor Peter Klinken, HLS5 Scientific Advisor



pklinken.jpgProfessor Peter Klinken is the Director of the Harry Perkins Institute of medical research, which is the State's premier adult medical research institute. 

Professor Klinken obtained his PhD in Biochemistry from The University of Western Australia in 1982 and was a Fogarty International Fellow at the US National Institutes of Health in Washington, between 1984 and 1986.  From there Peter returned to work at the Walter and Eliza Hall Institute in Melbourne as an NHMRC Postdoctoral Fellow between 1987 and 1988. 

In 1989 Peter became a Lecturer in Biochemistry at the University of Western Australia, before being appointed Professor in Clinical Biochemistry in 1994.  Between 2000 and 2002 Peter was the Director of Research at Royal Perth Hospital. 

Peter discovered the HLS5 Tumor Suppressor Gene back in 2004.  His research interests encompass the regulation of red blood cell formation and ability of leukemic cells to develop different features and functions.  Peter also has a long-standing interest in identifying genes which can cause cancer or leukemia.

Dr Louise Winteringham, HLS5 Senior Researcher


Thumbnail image for Winteringham Photo.jpgLouise came to Western Australia in 1990.  She worked and studied in the Department of Clinical Immunology a Royal Perth Hospital completing her MSc in 1994.  In 1998 she was awarded the Richard Walter Gibbon Fellowship from the Faculty of Medicine to undertake her PhD with Professor Klinken investigating the role of Myeloid Leukemia Factor 1 (Mlf1) in normal haemopoiesis and in Acute Myeloid Leukemia. 

Louise has a BSc in Cell Biology from the University of Auckland in New Zealand long with MSc in Immunology from the University of Western Australia.  She completed her PhD in Medicine and Pharmacology at the University of Western Australia in 2002 with her Thesis Title:  Analysis of Mlf1, a novel gene involved in leukaemia.

Louise is working on HLS5 in the Klinken Laboratory.  Her research interests are regulation of haemopoietic commitment and differentiation and haemopoietic progenitor/stem cell biology.  She is also interested in molecules affecting the development of Leukemia.



Email Subscription

Enter your email address below to receive our email updates